Literature DB >> 23975827

Lentiviral transduction of neuronal cells.

Hassen S Wollebo1, Baheru Woldemichaele, Martyn K White.   

Abstract

Here we describe a general method for the construction of a lentivirus vector using a specific example of the construction of a lentivirus containing the luciferase reporter gene under the control of two hypothetical promoters and derived HIV-1 based lentivirus expression vector pLVX-Puro. This method can be used to compare the strength and regulation of different promoters. In this example, the target cells for transduction are human primary fetal astrocytes but the method is applicable to any primary cell culture from the CNS or other tissue and can be used to examine the strength of a particular promoter in different cell types. HIV based lentivirus particles are prepared by transfection of 4 plasmids into 293T cells using the Fugene 6 transfection reagent.

Entities:  

Mesh:

Year:  2013        PMID: 23975827      PMCID: PMC4057373          DOI: 10.1007/978-1-62703-640-5_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

Review 1.  Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.

Authors:  Aaron C Logan; Carolyn Lutzko; Donald B Kohn
Journal:  Curr Opin Biotechnol       Date:  2002-10       Impact factor: 9.740

2.  Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations.

Authors:  Warren Denning; Suvendu Das; Siqi Guo; Jun Xu; John C Kappes; Zdenek Hel
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

Review 3.  Lentiviral vectors: basic to translational.

Authors:  Toshie Sakuma; Michael A Barry; Yasuhiro Ikeda
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

Review 4.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

5.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 6.  Gene therapy: promises and problems.

Authors:  A Pfeifer; I M Verma
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

7.  JC virus-induced changes in cellular gene expression in primary human astrocytes.

Authors:  Sujatha Radhakrishnan; Jessica Otte; Sahnila Enam; Luis Del Valle; Kamel Khalili; Jennifer Gordon
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Lentiviral Based Gene Transduction and Promoter Studies in Human Hematopoietic Stem Cells (hHSCs).

Authors:  N Varma; B Janic; M Ali; Asm Iskander; A Arbab
Journal:  J Stem Cells Regen Med       Date:  2011-04-01

10.  Lentivirus-mediated transgene delivery to the hippocampus reveals sub-field specific differences in expression.

Authors:  Lenneke W A van Hooijdonk; Muhammad Ichwan; Thomas F Dijkmans; Theo G Schouten; Marijke W A de Backer; Roger A H Adan; Fons J Verbeek; Erno Vreugdenhil; Carlos P Fitzsimons
Journal:  BMC Neurosci       Date:  2009-01-13       Impact factor: 3.288

  10 in total
  7 in total

1.  Effectiveness of lentivirus-mediated RNA interference targeting mouse tumor necrosis factor α in vitro and in vivo.

Authors:  Jibo Wang; Yingjie Zhao; Miaomiao Xin; Lin Pan; Liqin Wang; Kun Yang
Journal:  Exp Ther Med       Date:  2017-12-11       Impact factor: 2.447

2.  Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies.

Authors:  Tanmoy Mondal; Gururaj N Shivange; Rachisan Gt Tihagam; Evan Lyerly; Michael Battista; Divpriya Talwar; Roxanna Mosavian; Karol Urbanek; Narmeen S Rashid; J Chuck Harrell; Paula D Bos; Edward B Stelow; M Sharon Stack; Sanchita Bhatnagar; Jogender Tushir-Singh
Journal:  EMBO Mol Med       Date:  2021-02-15       Impact factor: 12.137

3.  An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins.

Authors:  Donatus Riemann; Andoniya Petkova; Thomas Dresbach; Rebecca Wallrafen
Journal:  J Vis Exp       Date:  2018-06-26       Impact factor: 1.355

4.  Construction and identification of an RNA interference lentiviral vector targeting the mouse TNF-α gene.

Authors:  Jibo Wang; Hongda Liang; Yingjie Zhao; Xiangping Liu; Kun Yang; Aihua Sui
Journal:  Exp Ther Med       Date:  2015-10-19       Impact factor: 2.447

5.  Lentiviral vector-mediated transduction of adult neural stem/progenitor cells isolated from the temporal tissues of epileptic patients.

Authors:  Sara Abdolahi; Azizollah Khodakaram-Tafti; Hadi Aligholi; Saeid Ziaei; Maryam Khaleghi Ghadiri; Walter Stummer; Ali Gorji
Journal:  Iran J Basic Med Sci       Date:  2020-03       Impact factor: 2.699

6.  A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors.

Authors:  Gururaj Shivange; Tanmoy Mondal; Evan Lyerly; Sanchita Bhatnagar; Charles N Landen; Shivani Reddy; Jonathan Kim; Britney Doan; Paula Riddle; Jogender Tushir-Singh
Journal:  Cell Rep       Date:  2021-11-02       Impact factor: 9.423

7.  CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.

Authors:  Hassen S Wollebo; Anna Bellizzi; Rafal Kaminski; Wenhui Hu; Martyn K White; Kamel Khalili
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.